We are live on ! Find out more
LCM

Lynx1 Capital Management Portfolio holdings

AUM $633M
1-Year Est. Return 173.22%
This Fund
S&P 500
This Quarter Est. Return
+30.11%
1 Year Est. Return
+173.22%
3 Year Est. Return
+779.42%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$115M
AUM Growth
–
Cap. Flow
+$102M
Cap. Flow %
89.13%
Top 10 Hldgs %
100%
Holding
10
New
10
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
MRUS
Merus
MRUS
+$22.1M
2
TVTX icon
Travere Therapeutics
TVTX
+$20.8M
3
ALPN
Alpine Immune Sciences Inc
ALPN
+$15.6M
4
BLU
BELLUS Health Inc.
BLU
+$13.3M
5
IMGN
Immunogen Inc
IMGN
+$13.2M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRUS
1
DELISTED
Merus
MRUS
$24.9M 21.74%
+783,398
New +$22.1M
TVTX icon
2
Travere Therapeutics
TVTX
$5.33B
$22.9M 19.96%
+737,061
New +$20.8M
ALPN
3
DELISTED
Alpine Immune Sciences Inc
ALPN
$17.5M 15.25%
+1,261,927
New +$15.6M
BLU
4
DELISTED
BELLUS Health Inc.
BLU
$16.1M 14.07%
+2,003,114
New +$13.3M
IMGN
5
DELISTED
Immunogen Inc
IMGN
$15.8M 13.79%
+2,129,531
New +$13.2M
PRDS
6
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$6.57M 5.74%
+401,593
New +$4.67M
THRX
7
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$5.19M 4.53%
+409,358
New +$6.18M
CBAY
8
DELISTED
Cymabay Therapeutics
CBAY
$4.14M 3.61%
+1,224,968
New +$4.65M
PVLA
9
Palvella Therapeutics
PVLA
$1.98B
$1.45M 1.26%
+4,791
New +$1.53M
OTIC
10
DELISTED
Otonomy, Inc.
OTIC
$62K 0.05%
+30,000
New +$61.6K

Similar funds

SWM
SilverOak Wealth Management Edina, Minnesota $632M AUM 18.6% 1-Year Est. Return
RFA
Rollins Financial Advisors New York City, New York $632M AUM 23.84% 1-Year Est. Return
WA
WFM Asia Road Town, Tortola, British Virgin Islands $632M AUM 14.51% 1-Year Est. Return
AMM
American Money Management Rancho Santa Fe, California $632M AUM 14.06% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
ACM
Arini Captial Management London, United Kingdom $634M AUM
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return

Lynx1 Capital Management's Q4 2021 Portfolio in Review

Q4 2021 is the first quarter with a 13F filing on record for Lynx1 Capital Management, which disclosed 10 positions worth $115M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Merus: 783,398 shares worth $24.9M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Lynx1 Capital Management's largest Q4 2021 buy was Merus: 783,398 shares worth $24.9M.
  • Lynx1 Capital Management's ten largest holdings make up 100% of its $115M portfolio in Q4 2021.
  • Lynx1 Capital Management disclosed 10 positions in Q4 2021, its first 13F filing on record.

Based on Lynx1 Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.